Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common form of renal cell carcinoma in adults, comprising approximately 80% of cases. The lethality of ccRCC rises significantly at stage III or beyond, emphasizing the need for early detection to enable timely therapeutic interventions. This study introduces a non-invasive and efficient classification method, Domain Adaptive Squeeze-and-Excitation Network (DASNet), for grading ccRCC through Computed Tomography (CT) images using advanced deep learning and machine learning techniques. The dataset is enhanced using MedAugment technology and balanced to improve generalization and classification performance. To mitigate overfitting, renal angiomyolipoma (AML) samples are incorporated, increasing data diversity and model robustness. EfficientNet and RegNet serve as foundational models, leveraging local feature extraction and Squeeze-and-Excitation (SE) attention mechanisms to enhance recognition accuracy across grades. Furthermore, Domain-Adversarial Neural Networks (DANNs) are employed to maintain consistency between source and target domains, bolstering the model's generalization ability. The proposed model achieves a classification accuracy of 97.50%, demonstrating efficacy in early ccRCC grade identification. These findings not only offer valuable clinical insights but also establish a foundation for broader application of deep learning in tumor detection.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12539-025-00693-8DOI Listing

Publication Analysis

Top Keywords

renal cell
8
cell carcinoma
8
deep learning
8
ccrcc
5
dasnet convolutional
4
convolutional neural
4
neural network
4
network attention
4
attention mechanism
4
mechanism ccrcc
4

Similar Publications

IFN-β, a type I interferon, has been used as a first-line therapy for patients with multiple sclerosis (MS) for more than 30 years; however, the cellular and molecular basis of its therapeutic efficacy remains unclear. Here, we first used experimental autoimmune encephalomyelitis (EAE), a mouse model for MS, to show that the therapeutic effects of IFN-β were associated with a down-regulation of microRNA-21 (miR-21) and pathogenic T17 (pT17) cells. In vitro experiments demonstrated that genetic knockout of miR-21 directly inhibited pathogenic T17 cell differentiation.

View Article and Find Full Text PDF

Background: Substantial advances have been made in therapeutics for IgA nephropathy. We conducted a systematic review and meta-analysis to evaluate the comparative efficacy and safety of existing and novel IgA nephropathy therapies.

Methods: We searched MEDLINE and Embase databases from inception to May 21, 2025 for Phase 2b and 3 multi-center, randomized, placebo-controlled trials enrolling patients with IgA nephropathy that reported treatment effects on proteinuria and/or estimated glomerular filtration rate (eGFR) slope.

View Article and Find Full Text PDF

Background: Clonal plasma cell disorders, such as multiple myeloma (MM), often cause excretion of monoclonal free light chains (MFLC) into urine that serve as diagnostic markers and can cause renal injury.

Content: Measures of urinary protein excretion (PEx) and MFLC excretion are parameters for diagnosing and managing plasma cell disorders, although the roles are evolving as new diagnostic tools are applied. Current guidelines dictate measuring PEx and MFLC excretion using 24-hour urine specimens, which have multiple shortcomings that compromise the quality of testing, delay results, and are burdensome for patients.

View Article and Find Full Text PDF

Acute kidney injury (AKI) is a group of common clinical syndromes characterized by a rapid decline in renal function over a short period of time. At present, the treatment methods are limited, and research is needed to identify drugs that could alleviate renal ischemia-reperfusion (I/R) injury. Tetramethylpyrazine (TMP) is a bioactive alkaloid extracted from the Chinese herbal medicine Chuanxiong.

View Article and Find Full Text PDF

Immunoglobulin A nephropathy (IgAN), the most prevalent primary glomerulonephritis globally, is characterized by mesangial IgA deposition and heterogeneous clinical trajectories. Historically, management relied on renin-angiotensin system inhibition and empirical immunosuppression, yet high lifetime kidney failure risk persists despite optimized care. This review synthesizes advances in molecular pathogenesis, highlighting how the traditional multi-hit hypothesis-while foundational for targeted therapy development-fails to capture IgAN's recurrent, self-amplifying nature.

View Article and Find Full Text PDF